• Happy New Year from OPA!
• HURRY! OPA Membership Expires TODAY

• REMINDER: Mandatory Cannabis Education Training Due March 2020
• Applying NAPRA’s Non-Sterile Compounding Standards into Practice
• Selling What You Can Do for Your Clients Program
• Medical Devices Training for Pharmacy Technicians

• Ask the Customer Experience and Administration Team

• OPA Secure Health Plan: All-in-one healthcare package

• Happy holidays from OPA!
• Have your say on common (minor) ailments
• Congratulations pharmacy graduates!

• Professional Development Clinical Bundle
• Professional Development Operational Bundle
• Professional Development Pharmacy Technician Bundle

• Ask the Practice Support Network
• Dell’s Biggest Boxing Week Ever
• OPA Membership Deadline is December 31, 2019

• What is Critical Illness insurance?

• Drug Shortage / Supply Health System Alert: Sterile Mineral Oil 100% - 30 ml vial
• Drug Shortage / Supply Health System Alert: Etoposide and Raltitrexed
• Drug Shortage / Supply Health System Alert: Raltitrexed 2mg/vial
• Drug Shortage / Supply Health System Alert: Etoposide

• DDD Notice No. 19194 Posted December 23, 2019 Executive Officer Notice: Updates to the Ontario Guidelines for Drug Submission and Evaluation
• DDD Notice No. 19193 posted December 23, 2019 Notice: Amendments to Ontario Regulation 201/96 made under the Ontario Drug Benefit Act and Regulation 935 under the Drug Interchangeability and Dispensing Fee Act to reduce Administrative Burden to Drug • • • Manufacturers and Pharmacies
• DDD Notice No. 19192 posted December 19, 2019 Drug Submission Notice: New Submission Deadline Time for Multiple Source Products
• DDD Notice No. 19191 posted December 16, 2019 Notice: Policy for Pharmacy Payments under the Long-Term Care Home Capitation Funding Model, 2020 - UPDATE

Atoma-brand Diphenhydramine Hydrochloride 2% Anti-Itch Cream - Advisory
U-Dream herbal sleep-aid products - Advisory
Important Safety Information on GILENYA (fingolimod) and the Risk of Congenital Malformations - Novartis Pharmaceuticals Canada Inc.
Health Product InfoWatch - Safety Updates: Polyethylene glycol 3350

• ICYMI: Vote on Toronto Star Op-ed and Tell Readers Why Pharmacists Should be Allowed to Prescribe for Common Ailments
• ICYMI: Ministry Announcement Brings Good News for Pharmacy
• Last Call to Submit Presentation Proposals for 2020 OPA Conference

• Managing Your Pharmacy: The Business Essentials
• Collaborating with Family Physicians: The Rx For Success
• Essential Cannabis Knowledge for Pharmacy Technicians Program

• Ask the Customer Experience Administration Team
• Dell’s Biggest Boxing Week Ever
• OPA Membership Deadline is December 31, 2019

• Professional Liability Insurance: "Claims Made" Versus "Occurrence"

• DDD Notice No. 19191 posted December 16, 2019 Notice: Policy for Pharmacy Payments under the Long-Term Care Home Capitation Funding Model, 2020
• DDD Notice No. 19190 posted December 16, 2019 Notice: Amendments to Ontario Regulation 201/96 made under the Ontario Drug Benefit Act to Improve the Value of Pharmacy Payments
• DDD Notice No. 19189 posted December 16, 2019 Notice: Amendments to Ontario Regulation 201/96 made under the Ontario Drug Benefit Act and Regulation 935 made under the Drug Interchangeability and Dispensing Fee Act
• DDD Notice No. 19188 posted December 13, 2019 ODB FORMULARY – EDITION NO. 43, Summary of Changes – December 2019
• DDD Notice No. 19185 posted December 12, 2019 Prescription Forgery Alert
• DDD Notice No. 19184 posted December 11, 2019 Prescription Forgery Alert

• Ontario College of Pharmacists Makes Headway on Minor Ailments
• Updated FAQs on "Improving the Value of Pharmacy Payments"
• Ontario Deprescribing in Long-Term Care Forum June 2019 Report
• Call for Presentations for OPA Annual Conference

• Applying NAPRA’s Non-Sterile Compounding Standards into Practice
• Selling What You Can Do for Your Clients Program
• Medical Devices Training for Pharmacy Technicians

• Ask the Practice Support Network
• OPA Membership Deadline is December 31, 2019

• Why Buy Life Insurance?

• Drug Shortage / Supply Health System Alert: Tamoxifen

• DDD Notice No. 19183 posted December 10, 2019 Prescription Forgery Alert
• DDD Notice No. 19182 posted December 10, 2019 Prescription Forgery Alert
• DDD Notice No.19178 posted December 6, 2019 Prescription Forgery Alert
• DDD Notice No.19177 posted December 6, 2019 Prescription Forgery Alert

• Health Canada evaluating NDMA in metformin drugs

• Advocacy in Action – OPA in the Trenches
• UofT Leslie Dan Faculty of Pharmacy Career Fair
• Call for Presentations for OPA Annual Conference
• Health Canada Guidance Document: Handling and Destruction of Post-consumer Returns Containing Controlled Substances

• Managing Your Pharmacy: The Business Essentials
• Collaborating with Family Physicians: The Rx For Success

• Last Week Before 2020 Early Bird Deadline Draw
• Ask the Customer Experience and Administration Team

• Simultaneously Practising in Ontario and One or Two Other Provinces

• DDD Notice No. 19176 posted November 29, 2019 Prescription Forgery Alert

• Important Safety Update on XELJANZ / XELJANZ XR (tofacitinib) – Risk of Thrombosis - Pfizer Canada ULC
• Nitrosamine - Information Update

• Attention Pharmacy Owners: Submit Responses to Reducing the Administrative Burden to Drug Manufacturers and Pharmacies - Deadline Wednesday, November 27, 2019
• Ontario College of Pharmacists' Council Approves First Set of Regulatory Amendments to Expand Scope
• Call for Presentations for OPA Annual Conference
• Vaccines4Life Launches "Identifying Barriers to Adult Influenza Vaccination in Canada" Report
• OPA Student Open Forum
• University of Toronto Lunch and Learn
• A Guide to Traveling with Medication

• Applying NAPRA’s Non-Sterile Compounding Standards into Practice
• Essential Cannabis Knowledge for Pharmacy Technicians Program
• Selling What You Can Do for Your Clients Program

• Ask the Practice Support Network
• 2020 Early Bird Membership Draw

• Planning to Retire or Move to Part B of the Register?

• DDD Notice No. 19175 posted November 22, 2019 ODB Formulary – Edition No. 43, Summary of Changes – November 2019

• Drug Shortage / Supply Health System Alert: PrTOMUDEX® (Raltitrexed disodium for Injection), 2mg / Vial
• Drug Shortage / Supply Health System Alert: Tamoxifen Supply Status

• Ayurvedic products - Advisory

• Antibiotic Awareness Week: November 18-24
• OPA Student Open Forum
• OPA at OnPharmUnited Annual Conference
• Green Shield Canada’s Pharmacist Deprescribing Program

• Billing 101: Ontario Drug Benefit (ODB) and Third-Party Insurance
• FREE! Take-Home Naloxone Program at Community Pharmacies
• FREE! Opioid Addiction and Substitution Therapy Free Live Webinar Series
• OPA Continuing Education Co-ordinators Share Best Practices

• Ask the Customer Experience and Administration Team
• ICYMI: Don't Forget to Renew Your PLI
• Special member rates on Toronto area attractions

• Are you a part of a Local Area Network (LAN) or Wide Area Network (WAN)?

• DDD Notice No. 19172 posted November 19, 2019 Prescription Forgery Alert
• DDD Notice No. 19171 posted November 18, 2019 Prescription Forgery Alert
• DDD Notice No. 19170 posted November 18, 2019 Prescription Forgery Alert
• DDD Notice No. 19168 posted November 13, 2019 Prescription Forgery Alert
• DDD Notice No. 19167 posted November 13, 2019 Prescription Forgery Alert

• Drug Shortage / Supply Health System Alert: Fludarabine 25mg/ml - 2ml vial

• ICYMI: OPA 2020 Membership Launch - Are You With Us?
• ICYMI: OPA Profession Update
• The Canadian Foundation for Pharmacy Pillar of Pharmacy Award: Honouring Sherry Peister
• Important Information About DIRC in 2020
• World Diabetes Day is November 14
• OPA Call for Presentations Coming Soon
• Reminder: Register for U of T Leslie Dan Faculty of Pharmacy Class of 8T9 30th year reunion

• How to Add Value to The Pharmacy Business as A Pharmacy Technician
• FREE! Opioid Addictions and Substitution Therapy Online Modules
• Paid Consultations - Opportunities and Timesavers

• Ask the Practice Support Network

• Professional Liability Insurance Claims Reporting

• DDD Notice No. 19165 posted November 7, 2019 Prescription Forgery Alert